Global Fund considers a return to Myanmar
THE Global Fund to fight AIDS, Tuberculosis and Malaria is encouraging applications that could mean a resumption of funding for programs in Myanmar during the coming year, it was revealed last week during a visit by members of the fund’s Geneva-based secretariat.
The visit comes after a four-year break in funding. The Global Fund terminated a US$98 million grant to Myanmar in 2005 amid differences with the government over restrictions on access to project areas.
A director of the Global Fund, Dr William Paton, spoke of the strong possibility of a resumption of funding in Myanmar during a function at the Sedona Hotel on February 25.
“It is not a good strategy for fighting diseases if you leave gaps or little hotspots. So whether it is a country or a part of a country that is not covered in this global effort to achieve this goal, we really need to work together to fill in those gaps,” he said.
“We would feel guilty if Myanmar was not able to access our finances,” he said.
Dr Paton praised the Three Diseases Fund, which replaced the role of the Global Fund in Myanmar in 2006.
“I would like to really pay tribute to the efforts of the 3DF that carried on the work here against these three diseases,” Dr Paton told the gathering of donors, representatives from international nongovernmental organisations and the private sector and people living with HIV/AIDS.
“I think you’ve had some remarkable achievements and progress here that allow us to have hope to see our financing resume – resume because there is a real gap,” he said.
“There are 75,000 people [living with HIV] who need anti-retrovirals in Myanmar to stay healthy or to stay alive; less than 20 percent are getting access – that would only cost a few hundred dollars a year – so we think that that is a gap that should be addressed,” he said.
Mr Bengt Ekman, the current chair of the 3DF and a minister at the Swedish embassy in Bangkok said that malaria remained the number one killer in Myanmar, which also had the highest prevalence rate of HIV/AIDS in Southeast Asia.
“We donors to the 3DF think it would be very welcome if the Global Fund started to fund the combating of these diseases. A scaling up of efforts in Myanmar is absolutely necessary,” said Mr Ekman, who also attended the function at the Sedona Hotel.
Mr Ekman said he hoped the 3DF, which is providing $100 million to Myanmar over five years, could work closely with the Global Fund should it resume funding.
“We see ourselves as partners in the efforts to combat these diseases,” he said. “Once a decision has been taken by the Global Fund, 3DF will conclude how we best can compliment each other for the maximum effect.”
Dr Sun Gang, the country director of the United Nation’s Agency on AIDS, was cautiously optimistic about a resumption of funding support from the Global Fund.
“We don’t want to offer false hope that we will definitely get the grants,” said Dr Sun. “I think the common concern from the donor society is to get more open access.”
“However, there has been some progress there because we have evidence that even after the declaration of the termination [by] the Global Fund, [its] supervision missions were still able to visit [the areas where they were working]. The 3DF have also been able to make supervision visits.”
The impact of a funding increase estimated at $200 million to $250 million over five years to combat the three diseases would be hugely significant, said Dr Frank Smithius, the country director of Medicins Sans Frontiers, Holland (AZG), one of the leading providers of anti-retroviral treatment (ART) for people living with HIV in Myanmar.
“Specifically for ART treatment we could see an increase of patients treated from approximately 15,000 treated now to 45,000 or more in 2015,” Dr Smithius said.
“That is of course a very good development but it is still insufficient and more money needs to be made available to prevent tens of thousands of preventable deaths in the coming years,” he said.
Dr Smithius, who met the Global Fund delegation last week, emphasised the low level of overseas development aid received by Myanmar compared to other countries in the region and the importance of ensuring access for Global Fund activities.
“Global Fund support comes with a number of requirements for implementation and monitoring of activities to make sure that the funds reach the beneficiaries,” he said.
“Access to monitor the activities is essential; we have to avoid that this Global Fund will be a failure.”
UNAIDS says there are an estimated 240,000 people with HIV in Myanmar, while the World Health Organisation estimates that there were 425,000 cases of malaria during 2007.
A former merchant seaman who is undergoing anti-retroviral treatment for HIV said last week that in other countries, organisations providing ART were searching for people with the disease to offer them treatment.
“Here, the people living with HIV are queuing up at agencies begging for the treatment,” he said. “ART changes the life of someone living with the disease – not just their health but also their chance of working.”

0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home